Sep 12 |
Moderna trims research budget, stock falls to lowest level in 10 months
|
Sep 12 |
Moderna Crashes After Slashing Its R&D Budget, Sales Guidance
|
Sep 12 |
Moderna lays out plan to slice research and development spending
|
Sep 12 |
Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs
|
Sep 12 |
Update: Moderna to Cut Annual R&D Spending by $1.1 Billion From 2027
|
Sep 12 |
Moderna forecasts lower sales next year, shares slide to four-year low
|
Sep 12 |
Moderna R&D Day Highlights Progress and Strategic Priorities
|
Sep 12 |
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
|
Sep 10 |
Carisma Therapeutics, Moderna Expand Collaboration Into Autoimmune Diseases
|
Sep 10 |
Moderna, Carisma deal expands with autoimmune targets
|